BioSpace News Archive

ARxIUM, a global provider of industry-leading pharmacy automation, workflow and consulting solutions, today announced the launch of its cGMP RIVA IV compounding system for 503B central-fill, hospital and outsourcing pharmacies

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Health Insurance Innovations, Inc.

As part of its mission to advance health equity in Minnesota, the Center for Prevention at Blue Cross and Blue Shield of Minnesota has released a podcast series, “The State We’re In,” where they investigate what it means to have fair and just opportunities to be healthy.

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce the appointment of Dr Joseph D Khoury as a Scientific Advisor to the Company’s established Scientific Advisory Board.

The Honourable Ginette Petitpas Taylor, Minister of Health and John Oliver and Parliamentary Secretary to the Minister of Health, will take part in the commemoration activities of World AIDS Day.

Food and Drug Administration (FDA) today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.

Brammer Bio (“Brammer”), a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO), was recognized by the Greater Gainesville Chamber of Commerce as the Manufacturing Company of the Year at its recent 2018 Business of the Year awards program.

In the ultimate act of service during Chicago’s cold holiday season, Midwest Orthopaedic at Rush (MOR) physicians and their staff, and medical students from Rush University Medical Center will provide complimentary foot health care and distribute socks and winter boots to homeless men and women at a shelter on Chicago’s west side.

UNC REX Healthcare plans to open a new Cancer Center across the street from its main Raleigh campus to meet the increasing need for oncology treatment and services, and serve patients from across Eastern North Carolina for generations to come.

The Biotechnology Innovation Organization (BIO) today announced preliminary programing for the upcoming BIO CEO & Investor Conference to be held February 11-12, 2019 in New York City.